Mackenzie Financial
SRNE

Mackenzie Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mackenzie Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,219
Closed -$22.3K – 1642
2022
Q4 		$22.3K Hold
25,219
– – ﹤0.01% 1397
2022
Q3 		$40K Sell
25,219
-811
-3% -$1.84K ﹤0.01% 1372
2022
Q2 		$52K Buy
26,030
+8,900
+52% +$15.4K ﹤0.01% 1395
2022
Q1 		$40K Buy
17,130
+2,024
+13% +$6.31K ﹤0.01% 1379
2021
Q4 		$70K Sell
15,106
-851
-5% -$5.28K ﹤0.01% 1383
2021
Q3 		$122K Buy
+15,957
New +$135K ﹤0.01% 1362

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Mackenzie Financial's SRNE Position: Q1 2023 in Review

Mackenzie Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 25,219 shares — an estimated $22.3K sold.

Mackenzie Financial first reported a position in SRNE in Q3 2021 and held it in 6 quarters. The position peaked at $122K in Q3 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Mackenzie Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Mackenzie Financial sold 25,219 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $22.3K.
  • Mackenzie Financial first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and held it in 6 quarters.
  • Mackenzie Financial's Sorrento Therapeutics, Inc. position peaked at $122K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.